PADI4 and neoplasm: An immunoprecipitation assay revealed the colocalization of PAD4 and CK, and PAD4 could citrullinate CK8, 18, and 19, making it resistant to caspase-mediated cleavage, thereby disrupting apoptosis and promoting tumor progression [29].